Daily trading records

Drugs Made In America Acquisition Stock Price on August 17, 2026

Direct answer

Drugs Made In America Acquisition closed at $10.72 on August 17, 2026.

The open was $10.72, the high was $10.72 and the low was $10.72.
Volume was 25,044. The change from the prior close was +$0.01 (+0.09%).

Get free Drugs Made In America Acquisition email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Review Drugs Made In America Acquisition's price trend and period performance.

The chart connects verified session closes from May 4, 2026 through August 17, 2026.

Closing-price trend by trading session

Period performance is calculated from verified trading sessions.

5-session performance

+0.09%

From the July 28, 2026 close of $10.71 to $10.72 on August 17, 2026.

20-session performance

+0.75%

From the July 1, 2026 close of $10.64 to $10.72 on August 17, 2026.

60-session performance

+1.42%

From the May 4, 2026 close of $10.57 to $10.72 on August 17, 2026.

Drugs Made In America Acquisition Historical prices
Historical pricesOpenHighLowCloseVolumePrior-close change
$10.72$10.72$10.72$10.7225,044+$0.01 (+0.09%)

Verified data

Open
$10.72
High
$10.72
Low
$10.72
Close
$10.72
Volume
25,044
Prior-close change
+$0.01 (+0.09%)

Read the frequently asked questions.

What was Drugs Made In America Acquisition's closing price on August 17, 2026?

Drugs Made In America Acquisition closed at $10.72 on August 17, 2026.

What were Drugs Made In America Acquisition's open, high and low on August 17, 2026?

The open was $10.72, the high was $10.72 and the low was $10.72.

How much did Drugs Made In America Acquisition change from the prior close on August 17, 2026?

The change from the prior close was +$0.01 (+0.09%).

What was Drugs Made In America Acquisition's volume on August 17, 2026?

Trading volume was 25,044 shares.

What is the source for Drugs Made In America Acquisition's daily prices?

Daily aggregate prices are provided by Polygon.